Fundamentals-based quality & risk · not a recommendation
IOL Chemicals & Pharmaceuticals Ltd scores 50/100 (Watch) on the Orion Score — moderate business quality (56), poor growth (14), strong balance-sheet safety (80) and fair valuation (43). A fundamentals-based quality & risk score, not a buy/sell recommendation.
Risk checks
Forensic accounting
Piotroski F = fundamental health (0–9, higher is better) · Altman Z = bankruptcy / distress risk · Beneish M = earnings-manipulation check
Technical / Momentum
Price Trend
75/100
Technical momentum companion — separate from the fundamentals-based Orion Score.
Unlock with Pro
Upgrade →Q4 FY2026
Revenue & Profit in ₹ Crores
| Quarter | Revenue | Net Profit | OPM | EPS |
|---|---|---|---|---|
| Q4 2026 | ₹619.45 | ₹53.16 | 11.7% | ₹1.81 |
| Q3 2026 | ₹580.39 | ₹20.58 | 6.4% | ₹0.70 |
| Q2 2026 | ₹567.53 | ₹29.97 | 6.5% | ₹1.02 |
| Q1 2026 | ₹551.69 | ₹33.93 | 7.7% | ₹1.16 |
| Q4 2025 | ₹527.78 | ₹31.42 | 8.4% | ₹1.07 |
Revenue & Profit in ₹ Crores (Yearly)
| Year | Revenue | Net Profit | EBITDA | OPM |
|---|---|---|---|---|
| FY 2026 | ₹2,319.06 | ₹137.64 | ₹279.14 | 8.1% |
| FY 2025 | ₹2,079.21 | ₹101.07 | ₹224.71 | 6.3% |
| FY 2024 | ₹2,118.96 | ₹134.43 | ₹255.4 | 7.9% |
| FY 2023 | ₹2,201.69 | ₹139.14 | ₹245.5 | 8.2% |
Top companies in the same sector by market cap
| Company | Mkt Cap | P/E | ROCE | ROE | D/E | OPM |
|---|---|---|---|---|---|---|
| IOLCP ★ | ₹3,865 Cr | 28.08 | 9.95% | 7.90% | 0.08x | 11.65% |
| SUNPHARMA | ₹4,27,609 Cr | 37.32 | 15.73% | 14.72% | 0.06x | 18.90% |
| MAXHEALTH | ₹95,110 Cr | 66.21 | 11.94% | 14.33% | 0.32x | 22.56% |
| AUROPHARMA | ₹88,228 Cr | 25.64 | 12.55% | 9.93% | 0.21x | 15.11% |
| ASTERDM | ₹71,372 Cr | 108.60 | 8.93% | 10.07% | 0.46x | 13.98% |
| ABBOTINDIA | ₹59,615 Cr | 38.42 | 36.14% | 34.46% | 0.04x | 27.01% |
All values in ₹ Crores
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total Assets | ₹2,382.07 | ₹2,244.4 | ₹2,022.13 | ₹1,962.3 |
| Equity | ₹1,687.66 | ₹1,611.51 | ₹1,507.72 | ₹1,392.48 |
| Total Debt | ₹117.04 | ₹32.76 | ₹79.81 | ₹43.95 |
| Cash | ₹78.17 | ₹7.69 | ₹1.39 | ₹3.23 |
| Net Debt | ₹38.87 | ₹25.07 | ₹78.24 | ₹39.52 |
| Working Capital | ₹541.43 | ₹559.77 | ₹464.13 | ₹567.42 |
Q1 FY2027
Quarter-over-Quarter Trend
| Quarter | Promoter | FII | DII | Public |
|---|---|---|---|---|
| Q1 FY2027 | 63.11% ↑ | 0.72% ↓ | 0.59% ↑ | 35.59% ↓ |
| Q3 FY2026 | 52.62% | 2.08% ↓ | 0.03% ↓ | 45.26% ↑ |
| Q2 FY2026 | 52.62% | 2.25% ↓ | 0.05% ↑ | 45.1% ↑ |
| Q1 FY2026 | 52.62% | 2.59% ↑ | 0.02% ↓ | 44.76% ↓ |
| Q4 FY2025 | 52.62% | 1.47% ↓ | 0.07% | 45.84% ↑ |
| Q3 FY2025 | 52.62% ↑ | 1.49% ↓ | 0.08% | 45.81% ↓ |
| Q2 FY2025 | 48.19% | 1.63% ↑ | 0.07% ↓ | 50.11% ↓ |
| Q1 FY2025 | 48.19% | 1.39% | 0.09% | 50.34% |
| Ex-Date | Action | Details |
|---|---|---|
| 2026-02-17 | DIVIDEND | Interim Dividend - Re 1 Per Share |
2 mutual fund schemes
Ask: "Is IOL Chemicals & Pharmaceuticals Ltd stock a good buy right now?" — Get RSI, MACD, ROCE + AI recommendation
Analyse with OrionGet free stock analysis, market insights, and investment ideas delivered to your inbox.
No spam. Unsubscribe anytime.
IOL Chemicals & Pharmaceuticals Ltd is listed on the NSE under the Healthcare sector, Pharmaceuticals industry. ISIN: INE485C01029. Track live share price, technical analysis, RSI, MACD, PE ratio, and smart money holdings on VestAI — India's AI-powered stock analysis platform.